What are pharmaceutical companies doing to address diseases facing developing countries?
As part of joint international efforts to improve public health, our companies are conducting research for diseases that afflict developing countries disproportionately. About 15 antiretrovirals are available today to address HIV/AIDS, and more than 100 new AIDS medicines are in the research and development pipeline. This represents a tremendous advance from 20 years ago, when AIDS was considered untreatable and incurable. But much remains to be done.
